Neogen Corporation

NEOG Healthcare Medical Devices

Neogen Corporation’s revenue for fiscal 2026 (year ended May 2026) was $870.4 million, down 2.72% from fiscal 2025. In the quarter to August 2026, revenue grew 6.51%, EPS fell 132.1%, free cash flow grew 135.8% and total debt fell 2.31%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

11.81 0.46 −3.75%
Market cap
$2.7B
P/E
0.0×
Fwd P/E
−36.3×
Dividend yield
—
F-score
5/9
Altman Z
1.11
Beneish M
−2.43
Dividend safety
n/a
Older periods Nov '25 Feb '26 May '26 Aug '26
P/E ratio

+8 more quarters

0.00 0.00 0.00 0.00
P/S ratio
1.46 2.79 2.23 2.85
P/FCF ratio
0.00 385.29 60.63 50.58
P/Operating CF
66.19 106.92 64.24 195.44
P/B ratio
0.61 1.15 0.93 1.21
EV/Sales
2.22 3.54 2.95 3.56
EV/EBITDA
19.72 35.22 25.10 26.66
EV/FCF
(109.37) 488.90 80.24 63.05
Current Ratio
3.91 3.92 3.82 3.90
Net Debt/EBITDA
26.95 24.27 15.73 20.69
Debt/Equity
0.38 0.38 0.38 0.37
Earnings Yield
(46.79%) (25.11%) (0.34%) (2.20%)
Free Cash Flow Yield
(1.39%) 0.26% 1.65% 1.98%
Free Cash Flow per Share
0.04 0.05 0.12 0.02
Book value per Share
9.68 9.66 9.62 9.57
Free Cash Flow
7.78 11.17 26.20 4.70
EV/EBIT
0.00 0.00 0.00 0.00
Other line items

Show all line items

Columns are period end dates · fundamentals updated 13 Oct 2026